STAAR Surgical vs UFP Technologies
UFP Technologies reported revenue of $603 million in fiscal 2025, 2.5 times STAAR Surgical's $239 million in fiscal 2025. STAAR Surgical's revenue fell 23.7% in its latest year, and UFP Technologies' grew 19.5%. STAAR Surgical had an operating margin of -38.3%, against 15.3% at UFP Technologies. Their fiscal years end in different months (January 2 and December 31), so the periods don't line up exactly.
Side by side
| STAAR Surgical | UFP Technologies | |
|---|---|---|
| Latest fiscal year | FY2025, Jan 2, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $239M | $603M |
| Revenue growth | −23.7% | 19.5% |
| Revenue growth a year, last 5 years | 7.9% | 27.4% |
| Gross margin | 76.2% | 28.3% |
| Operating margin | −38.3% | 15.3% |
| Net margin | −33.6% | 11.3% |
| Free cash flow | −$40M | — |
| Free cash flow margin | −16.7% | — |
| Return on capital | — | 14.4% |
| Net debt to EBITDA | — | 1.0x |
| Dividends and buybacks | $6M | $0M |
| Change in diluted share count | 0.9% | 0.2% |
| Last close | $25.21 | $303.47 |
| P/E at the last close | — | 30.9× |
| Insider trades, last 12 months | bought $62.8 million, sold $0 | sold $13.6 million |
| Piotroski F-score | — | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
STAAR SurgicalUFP Technologies
Operating margin
Percent of revenue
STAAR SurgicalUFP Technologies
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
STAAR SurgicalUFP Technologies
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the STAAR Surgical and UFP Technologies pages.